Global Pain Relievers Market Research Report 2023

Pain Relievers Market

The global Pain Relievers market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Pain Relievers is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Pain Relievers is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Pain Relievers in Headache is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Pain Relievers include Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo and Merck, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pain Relievers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pain Relievers.

The Pain Relievers market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pain Relievers market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pain Relievers companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of Pain Relievers Market Report

Core Chapters

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pain Relievers Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Nonsteroidal Anti-inflammatory Drugs

1.2.3 Central Analgesics

1.3 Market by Application

1.3.1 Global Pain Relievers Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Headache

1.3.3 Toothache

1.3.4 Arthralgia

1.3.5 Menstrual Pain

1.3.6 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Pain Relievers Market Perspective (2018-2029)

2.2 Pain Relievers Growth Trends by Region

2.2.1 Global Pain Relievers Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Pain Relievers Historic Market Size by Region (2018-2023)

2.2.3 Pain Relievers Forecasted Market Size by Region (2024-2029)

2.3 Pain Relievers Market Dynamics

2.3.1 Pain Relievers Industry Trends

2.3.2 Pain Relievers Market Drivers

2.3.3 Pain Relievers Market Challenges

2.3.4 Pain Relievers Market Restraints

3.1 Global Top Pain Relievers Players by Revenue

3.1.1 Global Top Pain Relievers Players by Revenue (2018-2023)

3.1.2 Global Pain Relievers Revenue Market Share by Players (2018-2023)

3.2 Global Pain Relievers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pain Relievers Revenue

3.4 Global Pain Relievers Market Concentration Ratio

3.4.1 Global Pain Relievers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pain Relievers Revenue in 2022

3.5 Pain Relievers Key Players Head office and Area Served

3.6 Key Players Pain Relievers Product Solution and Service

3.7 Date of Enter into Pain Relievers Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Pain Relievers Historic Market Size by Type (2018-2023)

4.2 Global Pain Relievers Forecasted Market Size by Type (2024-2029)

5.1 Global Pain Relievers Historic Market Size by Application (2018-2023)

5.2 Global Pain Relievers Forecasted Market Size by Application (2024-2029)

6.1 North America Pain Relievers Market Size (2018-2029)

6.2 North America Pain Relievers Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Pain Relievers Market Size by Country (2018-2023)

6.4 North America Pain Relievers Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Pain Relievers Market Size (2018-2029)

7.2 Europe Pain Relievers Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Pain Relievers Market Size by Country (2018-2023)

7.4 Europe Pain Relievers Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Pain Relievers Market Size (2018-2029)

8.2 Asia-Pacific Pain Relievers Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Pain Relievers Market Size by Region (2018-2023)

8.4 Asia-Pacific Pain Relievers Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Pain Relievers Market Size (2018-2029)

9.2 Latin America Pain Relievers Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Pain Relievers Market Size by Country (2018-2023)

9.4 Latin America Pain Relievers Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Pain Relievers Market Size (2018-2029)

10.2 Middle East & Africa Pain Relievers Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Pain Relievers Market Size by Country (2018-2023)

10.4 Middle East & Africa Pain Relievers Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Pain Relievers Introduction

11.1.4 Pfizer Revenue in Pain Relievers Business (2018-2023)

11.1.5 Pfizer Recent Development

11.2 GSK

11.2.1 GSK Company Detail

11.2.2 GSK Business Overview

11.2.3 GSK Pain Relievers Introduction

11.2.4 GSK Revenue in Pain Relievers Business (2018-2023)

11.2.5 GSK Recent Development

11.3 Grunenthal

11.3.1 Grunenthal Company Detail

11.3.2 Grunenthal Business Overview

11.3.3 Grunenthal Pain Relievers Introduction

11.3.4 Grunenthal Revenue in Pain Relievers Business (2018-2023)

11.3.5 Grunenthal Recent Development

11.4 Bayer

11.4.1 Bayer Company Detail

11.4.2 Bayer Business Overview

11.4.3 Bayer Pain Relievers Introduction

11.4.4 Bayer Revenue in Pain Relievers Business (2018-2023)

11.4.5 Bayer Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Detail

11.5.2 Sanofi Business Overview

11.5.3 Sanofi Pain Relievers Introduction

11.5.4 Sanofi Revenue in Pain Relievers Business (2018-2023)

11.5.5 Sanofi Recent Development

11.6 Eli Lilly

11.6.1 Eli Lilly Company Detail

11.6.2 Eli Lilly Business Overview

11.6.3 Eli Lilly Pain Relievers Introduction

11.6.4 Eli Lilly Revenue in Pain Relievers Business (2018-2023)

11.6.5 Eli Lilly Recent Development

11.7 AstraZeneca

11.7.1 AstraZeneca Company Detail

11.7.2 AstraZeneca Business Overview

11.7.3 AstraZeneca Pain Relievers Introduction

11.7.4 AstraZeneca Revenue in Pain Relievers Business (2018-2023)

11.7.5 AstraZeneca Recent Development

11.8 Endo

11.8.1 Endo Company Detail

11.8.2 Endo Business Overview

11.8.3 Endo Pain Relievers Introduction

11.8.4 Endo Revenue in Pain Relievers Business (2018-2023)

11.8.5 Endo Recent Development

11.9 Merck

11.9.1 Merck Company Detail

11.9.2 Merck Business Overview

11.9.3 Merck Pain Relievers Introduction

11.9.4 Merck Revenue in Pain Relievers Business (2018-2023)

11.9.5 Merck Recent Development

11.10 Depomed

11.10.1 Depomed Company Detail

11.10.2 Depomed Business Overview

11.10.3 Depomed Pain Relievers Introduction

11.10.4 Depomed Revenue in Pain Relievers Business (2018-2023)

11.10.5 Depomed Recent Development

11.11 Yunnan Baiyao

11.11.1 Yunnan Baiyao Company Detail

11.11.2 Yunnan Baiyao Business Overview

11.11.3 Yunnan Baiyao Pain Relievers Introduction

11.11.4 Yunnan Baiyao Revenue in Pain Relievers Business (2018-2023)

11.11.5 Yunnan Baiyao Recent Development

11.12 Teva

11.12.1 Teva Company Detail

11.12.2 Teva Business Overview

11.12.3 Teva Pain Relievers Introduction

11.12.4 Teva Revenue in Pain Relievers Business (2018-2023)

11.12.5 Teva Recent Development

11.13 J&J

11.13.1 J&J Company Detail

11.13.2 J&J Business Overview

11.13.3 J&J Pain Relievers Introduction

11.13.4 J&J Revenue in Pain Relievers Business (2018-2023)

11.13.5 J&J Recent Development

11.14 Allergan

11.14.1 Allergan Company Detail

11.14.2 Allergan Business Overview

11.14.3 Allergan Pain Relievers Introduction

11.14.4 Allergan Revenue in Pain Relievers Business (2018-2023)

11.14.5 Allergan Recent Development

11.15 Purdue

11.15.1 Purdue Company Detail

11.15.2 Purdue Business Overview

11.15.3 Purdue Pain Relievers Introduction

11.15.4 Purdue Revenue in Pain Relievers Business (2018-2023)

11.15.5 Purdue Recent Development

11.16 Reckitt Benckiser Group Plc

11.16.1 Reckitt Benckiser Group Plc Company Detail

11.16.2 Reckitt Benckiser Group Plc Business Overview

11.16.3 Reckitt Benckiser Group Plc Pain Relievers Introduction

11.16.4 Reckitt Benckiser Group Plc Revenue in Pain Relievers Business (2018-2023)

11.16.5 Reckitt Benckiser Group Plc Recent Development

11.17 Novartis AG

11.17.1 Novartis AG Company Detail

11.17.2 Novartis AG Business Overview

11.17.3 Novartis AG Pain Relievers Introduction

11.17.4 Novartis AG Revenue in Pain Relievers Business (2018-2023)

11.17.5 Novartis AG Recent Development

11.18 Topical BioMedics

11.18.1 Topical BioMedics Company Detail

11.18.2 Topical BioMedics Business Overview

11.18.3 Topical BioMedics Pain Relievers Introduction

11.18.4 Topical BioMedics Revenue in Pain Relievers Business (2018-2023)

11.18.5 Topical BioMedics Recent Development

11.19 AdvaCare Pharma

11.19.1 AdvaCare Pharma Company Detail

11.19.2 AdvaCare Pharma Business Overview

11.19.3 AdvaCare Pharma Pain Relievers Introduction

11.19.4 AdvaCare Pharma Revenue in Pain Relievers Business (2018-2023)

11.19.5 AdvaCare Pharma Recent Development

11.20 Sun Pharmaceutical

11.20.1 Sun Pharmaceutical Company Detail

11.20.2 Sun Pharmaceutical Business Overview

11.20.3 Sun Pharmaceutical Pain Relievers Introduction

11.20.4 Sun Pharmaceutical Revenue in Pain Relievers Business (2018-2023)

11.20.5 Sun Pharmaceutical Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Pain Relievers Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Nonsteroidal Anti-inflammatory Drugs

    Table 3. Key Players of Central Analgesics

    Table 4. Global Pain Relievers Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Pain Relievers Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Pain Relievers Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Pain Relievers Market Share by Region (2018-2023)

    Table 8. Global Pain Relievers Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Pain Relievers Market Share by Region (2024-2029)

    Table 10. Pain Relievers Market Trends

    Table 11. Pain Relievers Market Drivers

    Table 12. Pain Relievers Market Challenges

    Table 13. Pain Relievers Market Restraints

    Table 14. Global Pain Relievers Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Pain Relievers Market Share by Players (2018-2023)

    Table 16. Global Top Pain Relievers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pain Relievers as of 2022)

    Table 17. Ranking of Global Top Pain Relievers Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Pain Relievers Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Pain Relievers Product Solution and Service

    Table 21. Date of Enter into Pain Relievers Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Pain Relievers Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Pain Relievers Revenue Market Share by Type (2018-2023)

    Table 25. Global Pain Relievers Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Pain Relievers Revenue Market Share by Type (2024-2029)

    Table 27. Global Pain Relievers Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Pain Relievers Revenue Market Share by Application (2018-2023)

    Table 29. Global Pain Relievers Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Pain Relievers Revenue Market Share by Application (2024-2029)

    Table 31. North America Pain Relievers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Pain Relievers Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Pain Relievers Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Pain Relievers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Pain Relievers Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Pain Relievers Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Pain Relievers Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Pain Relievers Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Pain Relievers Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Pain Relievers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Pain Relievers Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Pain Relievers Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Pain Relievers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Pain Relievers Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Pain Relievers Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Pfizer Company Detail

    Table 47. Pfizer Business Overview

    Table 48. Pfizer Pain Relievers Product

    Table 49. Pfizer Revenue in Pain Relievers Business (2018-2023) & (US$ Million)

    Table 50. Pfizer Recent Development

    Table 51. GSK Company Detail

    Table 52. GSK Business Overview

    Table 53. GSK Pain Relievers Product

    Table 54. GSK Revenue in Pain Relievers Business (2018-2023) & (US$ Million)

    Table 55. GSK Recent Development

    Table 56. Grunenthal Company Detail

    Table 57. Grunenthal Business Overview

    Table 58. Grunenthal Pain Relievers Product

    Table 59. Grunenthal Revenue in Pain Relievers Business (2018-2023) & (US$ Million)

    Table 60. Grunenthal Recent Development

    Table 61. Bayer Company Detail

    Table 62. Bayer Business Overview

    Table 63. Bayer Pain Relievers Product

    Table 64. Bayer Revenue in Pain Relievers Business (2018-2023) & (US$ Million)

    Table 65. Bayer Recent Development

    Table 66. Sanofi Company Detail

    Table 67. Sanofi Business Overview

    Table 68. Sanofi Pain Relievers Product

    Table 69. Sanofi Revenue in Pain Relievers Business (2018-2023) & (US$ Million)

    Table 70. Sanofi Recent Development

    Table 71. Eli Lilly Company Detail

    Table 72. Eli Lilly Business Overview

    Table 73. Eli Lilly Pain Relievers Product

    Table 74. Eli Lilly Revenue in Pain Relievers Business (2018-2023) & (US$ Million)

    Table 75. Eli Lilly Recent Development

    Table 76. AstraZeneca Company Detail

    Table 77. AstraZeneca Business Overview

    Table 78. AstraZeneca Pain Relievers Product

    Table 79. AstraZeneca Revenue in Pain Relievers Business (2018-2023) & (US$ Million)

    Table 80. AstraZeneca Recent Development

    Table 81. Endo Company Detail

    Table 82. Endo Business Overview

    Table 83. Endo Pain Relievers Product

    Table 84. Endo Revenue in Pain Relievers Business (2018-2023) & (US$ Million)

    Table 85. Endo Recent Development

    Table 86. Merck Company Detail

    Table 87. Merck Business Overview

    Table 88. Merck Pain Relievers Product

    Table 89. Merck Revenue in Pain Relievers Business (2018-2023) & (US$ Million)

    Table 90. Merck Recent Development

    Table 91. Depomed Company Detail

    Table 92. Depomed Business Overview

    Table 93. Depomed Pain Relievers Product

    Table 94. Depomed Revenue in Pain Relievers Business (2018-2023) & (US$ Million)

    Table 95. Depomed Recent Development

    Table 96. Yunnan Baiyao Company Detail

    Table 97. Yunnan Baiyao Business Overview

    Table 98. Yunnan Baiyao Pain Relievers Product

    Table 99. Yunnan Baiyao Revenue in Pain Relievers Business (2018-2023) & (US$ Million)

    Table 100. Yunnan Baiyao Recent Development

    Table 101. Teva Company Detail

    Table 102. Teva Business Overview

    Table 103. Teva Pain Relievers Product

    Table 104. Teva Revenue in Pain Relievers Business (2018-2023) & (US$ Million)

    Table 105. Teva Recent Development

    Table 106. J&J Company Detail

    Table 107. J&J Business Overview

    Table 108. J&J Pain Relievers Product

    Table 109. J&J Revenue in Pain Relievers Business (2018-2023) & (US$ Million)

    Table 110. J&J Recent Development

    Table 111. Allergan Company Detail

    Table 112. Allergan Business Overview

    Table 113. Allergan Pain Relievers Product

    Table 114. Allergan Revenue in Pain Relievers Business (2018-2023) & (US$ Million)

    Table 115. Allergan Recent Development

    Table 116. Purdue Company Detail

    Table 117. Purdue Business Overview

    Table 118. Purdue Pain Relievers Product

    Table 119. Purdue Revenue in Pain Relievers Business (2018-2023) & (US$ Million)

    Table 120. Purdue Recent Development

    Table 121. Reckitt Benckiser Group Plc Company Detail

    Table 122. Reckitt Benckiser Group Plc Business Overview

    Table 123. Reckitt Benckiser Group Plc Pain Relievers Product

    Table 124. Reckitt Benckiser Group Plc Revenue in Pain Relievers Business (2018-2023) & (US$ Million)

    Table 125. Reckitt Benckiser Group Plc Recent Development

    Table 126. Novartis AG Company Detail

    Table 127. Novartis AG Business Overview

    Table 128. Novartis AG Pain Relievers Product

    Table 129. Novartis AG Revenue in Pain Relievers Business (2018-2023) & (US$ Million)

    Table 130. Novartis AG Recent Development

    Table 131. Topical BioMedics Company Detail

    Table 132. Topical BioMedics Business Overview

    Table 133. Topical BioMedics Pain Relievers Product

    Table 134. Topical BioMedics Revenue in Pain Relievers Business (2018-2023) & (US$ Million)

    Table 135. Topical BioMedics Recent Development

    Table 136. AdvaCare Pharma Company Detail

    Table 137. AdvaCare Pharma Business Overview

    Table 138. AdvaCare Pharma Pain Relievers Product

    Table 139. AdvaCare Pharma Revenue in Pain Relievers Business (2018-2023) & (US$ Million)

    Table 140. AdvaCare Pharma Recent Development

    Table 141. Sun Pharmaceutical Company Detail

    Table 142. Sun Pharmaceutical Business Overview

    Table 143. Sun Pharmaceutical Pain Relievers Product

    Table 144. Sun Pharmaceutical Revenue in Pain Relievers Business (2018-2023) & (US$ Million)

    Table 145. Sun Pharmaceutical Recent Development

    Table 146. Research Programs/Design for This Report

    Table 147. Key Data Information from Secondary Sources

    Table 148. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Pain Relievers Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Pain Relievers Market Share by Type: 2022 VS 2029

    Figure 3. Nonsteroidal Anti-inflammatory Drugs Features

    Figure 4. Central Analgesics Features

    Figure 5. Global Pain Relievers Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Pain Relievers Market Share by Application: 2022 VS 2029

    Figure 7. Headache Case Studies

    Figure 8. Toothache Case Studies

    Figure 9. Arthralgia Case Studies

    Figure 10. Menstrual Pain Case Studies

    Figure 11. Other Case Studies

    Figure 12. Pain Relievers Report Years Considered

    Figure 13. Global Pain Relievers Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Pain Relievers Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Pain Relievers Market Share by Region: 2022 VS 2029

    Figure 16. Global Pain Relievers Market Share by Players in 2022

    Figure 17. Global Top Pain Relievers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pain Relievers as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Pain Relievers Revenue in 2022

    Figure 19. North America Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Pain Relievers Market Share by Country (2018-2029)

    Figure 21. United States Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Pain Relievers Market Share by Country (2018-2029)

    Figure 25. Germany Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Pain Relievers Market Share by Region (2018-2029)

    Figure 33. China Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Pain Relievers Market Share by Country (2018-2029)

    Figure 41. Mexico Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Pain Relievers Market Share by Country (2018-2029)

    Figure 45. Turkey Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Pain Relievers Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Pfizer Revenue Growth Rate in Pain Relievers Business (2018-2023)

    Figure 48. GSK Revenue Growth Rate in Pain Relievers Business (2018-2023)

    Figure 49. Grunenthal Revenue Growth Rate in Pain Relievers Business (2018-2023)

    Figure 50. Bayer Revenue Growth Rate in Pain Relievers Business (2018-2023)

    Figure 51. Sanofi Revenue Growth Rate in Pain Relievers Business (2018-2023)

    Figure 52. Eli Lilly Revenue Growth Rate in Pain Relievers Business (2018-2023)

    Figure 53. AstraZeneca Revenue Growth Rate in Pain Relievers Business (2018-2023)

    Figure 54. Endo Revenue Growth Rate in Pain Relievers Business (2018-2023)

    Figure 55. Merck Revenue Growth Rate in Pain Relievers Business (2018-2023)

    Figure 56. Depomed Revenue Growth Rate in Pain Relievers Business (2018-2023)

    Figure 57. Yunnan Baiyao Revenue Growth Rate in Pain Relievers Business (2018-2023)

    Figure 58. Teva Revenue Growth Rate in Pain Relievers Business (2018-2023)

    Figure 59. J&J Revenue Growth Rate in Pain Relievers Business (2018-2023)

    Figure 60. Allergan Revenue Growth Rate in Pain Relievers Business (2018-2023)

    Figure 61. Purdue Revenue Growth Rate in Pain Relievers Business (2018-2023)

    Figure 62. Reckitt Benckiser Group Plc Revenue Growth Rate in Pain Relievers Business (2018-2023)

    Figure 63. Novartis AG Revenue Growth Rate in Pain Relievers Business (2018-2023)

    Figure 64. Topical BioMedics Revenue Growth Rate in Pain Relievers Business (2018-2023)

    Figure 65. AdvaCare Pharma Revenue Growth Rate in Pain Relievers Business (2018-2023)

    Figure 66. Sun Pharmaceutical Revenue Growth Rate in Pain Relievers Business (2018-2023)

    Figure 67. Bottom-up and Top-down Approaches for This Report

    Figure 68. Data Triangulation

    Figure 69. Key Executives Interviewed